chrX-71100738-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_005938.4(FOXO4):c.508G>A(p.Glu170Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000498 in 1,205,439 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005938.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXO4 | NM_005938.4 | c.508G>A | p.Glu170Lys | missense_variant | 2/3 | ENST00000374259.8 | NP_005929.2 | |
FOXO4 | NM_001170931.2 | c.343G>A | p.Glu115Lys | missense_variant | 3/4 | NP_001164402.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXO4 | ENST00000374259.8 | c.508G>A | p.Glu170Lys | missense_variant | 2/3 | 1 | NM_005938.4 | ENSP00000363377.3 | ||
FOXO4 | ENST00000341558.3 | c.343G>A | p.Glu115Lys | missense_variant | 3/4 | 5 | ENSP00000342209.3 | |||
FOXO4 | ENST00000464598.1 | n.201G>A | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
FOXO4 | ENST00000466874.1 | n.623G>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000905 AC: 1AN: 110451Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32725
GnomAD4 exome AF: 0.00000457 AC: 5AN: 1094988Hom.: 0 Cov.: 32 AF XY: 0.00000277 AC XY: 1AN XY: 360740
GnomAD4 genome AF: 0.00000905 AC: 1AN: 110451Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32725
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.508G>A (p.E170K) alteration is located in exon 2 (coding exon 2) of the FOXO4 gene. This alteration results from a G to A substitution at nucleotide position 508, causing the glutamic acid (E) at amino acid position 170 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at